Lastly, we translated our findings to a CD4+ T cell-mediated disease and we demonstrated that the neutralization of PlexinD1 suppressed the CD4+ T cell secretion of IL-17 and IL-4 induced by the serum of SSc patients. Here, IL17A is linked to systemic sclerosis.